Dow Up 0.03% Nasdaq Down 0.06%

Alcobra Ltd. (ADHD)

-NasdaqGM
5.22 Up 0.10(1.95%) 10:13AM EDT - Nasdaq Real Time Price
Prev Close:5.12
Open:5.26
Bid:5.13 x 500
Ask:5.18 x 700
1y Target Est:23.67
Beta:1.935
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:5.11 - 5.27
52wk Range:5.01 - 25.44
Volume:56,773
Avg Vol (3m):414,789
Market Cap:71.32M
P/E (ttm):N/A
EPS (ttm):-1.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ADHDUp 1.95%71.32M
JNJUp 0.85%285.44B
NVSDown 0.03%214.91B
SHPGUp 1.22%36.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.20
Quarterly EPS Est (Sep-14) :-0.56
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of proprietary drug candidates. It offers most advanced product (MDX) for the treatment of attention deficit hyperactivity disorder (ADHD) and other cognit... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback